# Progesterone and Resting Energy Expenditure

> **NCT04140968** · PHASE4 · TERMINATED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 2 (actual)

## Conditions studied

- Menopause
- Progesterone
- Weight Gain

## Interventions

- **DRUG:** Utrogestan

## Key facts

- **NCT ID:** NCT04140968
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-01
- **Primary completion:** 2021-05-27
- **Final completion:** 2021-05-27
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** massive recruitment problems became apparent because of the strict inclusion criteria of our study.
- **Last updated:** 2022-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04140968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04140968, "Progesterone and Resting Energy Expenditure". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04140968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*